MBC BioLabs Announces New Partnership with RWD Life Sciences

[San Francisco, CA – June 2, 2025] – MBC BioLabs is proud to announce it has entered into a partnership with RWD Life Sciences. This partnership will help support the mission of enabling awesome for MBC BioLabs’ community of high-growth biotech start-up companies.
About RWD Life Sciences
RWD Life Science, founded in 2002, is a global leading manufacturer of scientific equipment, committed to provide high-quality and cost-effective laboratory instruments to researchers worldwide. We offer comprehensive solutions including animal surgery and modeling, neuroscience research, animal behavior research, cell and molecular biology, microcirculation monitoring, pathological diagnosis, and animal healthcare. To date, we have served over 10,000 laboratories worldwide, including renowned universities, research institutions, and veterinary facilities. Our R&D team holds nearly 100 patents in fields such as neuroscience and molecular/cellular research, demonstrating our commitment to innovation. We are dedicated to advancing the development of the life science industry, and look forward to further supporting the life science community through our collaboration with MBC BioLabs.
For more information, please visit our official website at www.rwdstco.com or follow us on LinkedIn by searching for “RWD Life Science”.
About MBC BioLabs
At MBC BioLabs, we believe that startups are the greatest force for positive change in the world. We are dedicated to helping biotech startups succeed – we like to say that we enable awesome. We offer flexible and cost-effective lab space, complete with operational support and millions of dollars’ worth of state-of-the-art equipment and instrumentation, along with a vibrant community of like-minded individuals tackling the world’s biggest problems.
We have helped launch and grow over 400 companies since opening in October of 2013, and together, MBC companies have initiated 176 clinical trials, introduced 135 products to market, and collectively raised over $20 billion. Learn more at mbcbiolabs.com.